Jn 65/24 Reagents for the Biochemical Laboratory, for the Treatment of Uninsured Persons

SerbiaTenders notice for Jn 65/24 Reagents for the Biochemical Laboratory, for the Treatment of Uninsured Persons. The reference ID of the tender is 111058709 and it is closing on 23 Dec 2024.

100% Secure Payments

Tender Details

  • Country: Serbia
  • Summary: Jn 65/24 Reagents for the Biochemical Laboratory, for the Treatment of Uninsured Persons
  • RST Ref No: 111058709
  • Deadline: 23 Dec 2024
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: JN 65/24
  • Purchaser's Detail :
  • Purchaser : "DEDINJE" INSTITUTE FOR CARDIOVASCULAR DISEASES
    RS110 - Belgrade region, BELGRADE
    Email :dean.firkelj@gmail.com

  • Description :
  • Lot 1: Reagents and consumables for immunochemical analyzers MAGLUMI 4000 Plus, Maglumi 2000 Plus, Maglumi 2000, Maglumi 1000 and Maglumi 800 (SNIBE), Lot 2: Reagents and consumables for immunochemical, biochemical and hematological analyzers model ACCESS; DxI600 and DxI800, AU480,
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
SerbiaTenders Features

SerbiaTenders Features

Fresh and verified Tenders from Serbia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Serbia in your email inbox.

  Chat with us